Zhou Jian, Wang Jie, Penny Dina, Monget Philippe, Arraztoa Jose A, Fogelson Larry J, Bondy Carolyn A
Developmental Endocrinology Branch, NICHD, NIH, Bethesda, Maryland 20892, USA.
Biol Reprod. 2003 Jul;69(1):22-9. doi: 10.1095/biolreprod.102.009191. Epub 2003 Jan 8.
It has been suggested that locally produced insulin-like growth factor binding protein 4 (IGFBP4) inhibits ovarian follicular growth and ovulation by interfering with IGF action. According to this hypothesis, IGFBP4-expressing follicles should demonstrate atresia, whereas healthy dominant follicles should be devoid of IGFBP4. Alternatively, according to this view, there could be constitutive expression of the inhibitory IGFBP4 but selective expression of an IGFBP4 protease in dominant follicles, allowing the follicle to mature and ovulate because of degradation of the binding protein. To examine these views concerning the role of IGFBP4 in primate follicular selection, we analyzed cellular patterns of IGFs 1 and 2, IGFBP4, and the IGFBP4 protease (pregnancy-associated plasma protein A [PAPP-A]) mRNA expression in ovaries from late follicular phase rhesus monkeys using in situ hybridization. The IGF1 mRNA was not detected, but the IGF2 mRNA was abundant in theca interna and externa of all antral follicles and was present in the granulosa of large preovulatory and ovulatory follicles. The IGFBP4 mRNA was selectively expressed by LH receptor (LHR) mRNA-positive theca interna cells of healthy antral follicles (defined by aromatase and gonadotropin receptor expression) and by LHR-expressing granulosa cells found only in large preovulatory and ovulatory follicles (defined by size and aromatase expression). The PAPP-A mRNA was abundant in granulosa cells of most follicles without obvious relation to IGFBP4 expression. Ovarian IGFBP4 mRNA levels were markedly increased after treatment with the LH analog, hCG, whereas IGF2 and PAPP-A mRNAs were not significantly altered. In summary, IGFBP4 expression appears to be associated with follicular selection, not with atresia, in the monkey ovary. The IGFBP4 is consistently expressed in healthy theca interna and in luteinized granulosa cells, likely under LH regulation. The IGFBP4 protease, PAPP-A, is widely expressed without apparent selectivity for IGFBP4-expressing follicles or for dominant follicles. These observations suggest that IGFBP4 or an IGFBP4 proteolytic product may be involved with LH-induced steroidogenesis and/or luteinization rather than with inhibition of follicular growth.
有人提出,局部产生的胰岛素样生长因子结合蛋白4(IGFBP4)通过干扰IGF的作用来抑制卵巢卵泡生长和排卵。根据这一假说,表达IGFBP4的卵泡应该表现出闭锁,而健康的优势卵泡应该没有IGFBP4。或者,根据这一观点,可能存在抑制性IGFBP4的组成性表达,但在优势卵泡中存在IGFBP4蛋白酶的选择性表达,由于结合蛋白的降解,使得卵泡能够成熟并排卵。为了研究这些关于IGFBP4在灵长类动物卵泡选择中作用的观点,我们使用原位杂交分析了来自卵泡晚期恒河猴卵巢中IGF-1和IGF-2、IGFBP4以及IGFBP4蛋白酶(妊娠相关血浆蛋白A [PAPP-A])mRNA表达的细胞模式。未检测到IGF-1 mRNA,但IGF-2 mRNA在所有窦状卵泡的内膜和外膜中丰富,并且存在于大的排卵前和排卵卵泡的颗粒细胞中。IGFBP4 mRNA由健康窦状卵泡(由芳香化酶和促性腺激素受体表达定义)的LH受体(LHR)mRNA阳性的内膜细胞以及仅在大的排卵前和排卵卵泡(由大小和芳香化酶表达定义)中发现的表达LHR的颗粒细胞选择性表达。PAPP-A mRNA在大多数卵泡的颗粒细胞中丰富,与IGFBP4表达无明显关系。用LH类似物hCG处理后,卵巢IGFBP4 mRNA水平显著升高,而IGF-2和PAPP-A mRNA没有明显改变。总之,在猴卵巢中,IGFBP4表达似乎与卵泡选择相关,而不是与闭锁相关。IGFBP4在健康的内膜和黄体化颗粒细胞中持续表达,可能受LH调节。IGFBP4蛋白酶PAPP-A广泛表达,对表达IGFBP4的卵泡或优势卵泡没有明显的选择性。这些观察结果表明,IGFBP4或IGFBP4蛋白水解产物可能参与LH诱导的类固醇生成和/或黄体化,而不是抑制卵泡生长。